Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters

Abstract
No abstract available
Funding Information
  • National Cancer Institute (1K07CA216326-01A1, R01 1R01CA211723-01A1)
  • Children's Hospital Colorado (1K24DK100303)
  • Consortium for Gastrointestinal Eosinophilic Researchers (U54 AI117804)
  • National Center for Advancing Translational Sciences
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • NCATS
  • American Partnership for Eosinophilic Disorders
  • Campaign Urging Research for Eosinophilic Disease
  • NIAID (R01, K24 AI)
  • CEGIR (U54 AI117804)
  • University of California
  • National Institutes of Health
  • Agency for Healthcare Quality and Research (#5K08HS024599-02)
  • CEGIR (U54 AI117804)
  • National Institutes of Health (R01DK101856)
  • Abbot
  • AstraZeneca
  • Celgene
  • Lilly
  • Regeneron